Evaluation of the Mixture Myoinositol:D-chiro-inositol 3.6:1 in Women With Polycystic Ovary Syndrome
Comparison of the Effect of a Combination of Myoinositol:D-chiro-inositol With Low Proportion of DCI (40:1) Versus a Combination With a Higher Proportion of DCI (3.6:1) in the Oocyte Quality and Pregnancy Rates in Women With PCOS
Sponsor: Biosearch S.A.
A PHASE2/PHASE3 clinical study on Infertility and Polycystic Ovarian Syndrome, this trial is completed. The trial is conducted by Biosearch S.A. and has accumulated 7 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2_PHASE3
-
Feb 2019 — Jan 2021 [monthly]
Completed PHASE2_PHASE3
Status: Unknown Status → Completed
-
Nov 2018 — Feb 2019 [monthly]
Unknown Status PHASE2_PHASE3
Status: Active Not Recruiting → Unknown Status
▶ Show 2 earlier versions
-
Jun 2018 — Nov 2018 [monthly]
Active Not Recruiting PHASE2_PHASE3
-
Jul 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE2_PHASE3
First recorded
Feb 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Biosearch S.A.
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.